U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975787) titled 'Dose Escalation Study With Bispecific Antibodies in Adult Patients With Lupus Nephritis' on May 08.
Brief Summary: This study is researching a particular group of experimental drugs administered for a short period in the treatment of patients with lupus nephritis (LN).
The main aim of the current study is to see how safe and tolerable the study drugs are in a long-term follow-up.
This is a main study, called an umbrella study, which includes several independent smaller sub-studies. Each of these smaller main sub-studies tests different drugs at the same time, all aimed at treating LN.
The study is looking at several other research...